ArticlePharmaceuticals (Basel, Switzerland)2023

Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds.

Emre F Bülbül et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.